14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
DVA vs PACS: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
DVA Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 8–2 Matrix Metrics)
DVA Overall Winner
6-Pillar Tally: DVA 5 – 1 PACS
Matrix Metrics: DVA 8 – 2 PACS
As of Nov 20, 2026, DaVita Inc. (DVA) is the stronger overall head-to-head candidate over PACS Group, Inc. (PACS) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). DVA carries a Unified Composite Score of 48.8/100 (HOLD) at $161.03 (9.5x Forward P/E, 15.2% operating margin), whereas PACS carries 46.8/100 (HOLD) at $43.67 (15.3x Forward P/E, 7.4% operating margin).
Technical & Structure Timing Caution: DVA is currently in a Breakdown options structure phase (RSI 35.6); meanwhile PACS trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 39.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Competes within the Medical Care Facilities value chain with $6.8B market capitalization and 7.4% operating margin.
OpEx & R&D Reinvestment10.4% of Rev ($593M)
90D Engineering Disclosures0 Published
Investor FAQ DVA vs PACS Key Questions & Quantitative Answers
As of Nov 20, 2026, DaVita Inc. (DVA) is the stronger overall head-to-head candidate over PACS Group, Inc. (PACS) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). DVA carries a Unified Composite Score of 48.8/100 (HOLD) at $161.03 (9.5x Forward P/E, 15.2% operating margin), whereas PACS carries 46.8/100 (HOLD) at $43.67 (15.3x Forward P/E, 7.4% operating margin). Technical & Structure Timing Caution: DVA is currently in a Breakdown options structure phase (RSI 35.6); meanwhile PACS trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 39.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
DVA leads the Growth & Scale pillar: DVA posts +4.6% YoY revenue growth and +66.7% YoY earnings growth on $14.2B TTM revenue (32.3% gross margin, 15.2% operating margin), compared with PACS at +11.5% YoY revenue growth and +15.6% YoY earnings growth on $5.71B TTM revenue (17.8% gross margin, 7.4% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), DVA cumulative revenue shifted +19.6% while PACS shifted +120.4%. In operating R&D and SG&A reinvestment, DVA deploys 17.1% of Rev ($2.42B) (0 90-day corporate R&D disclosures) versus 10.4% of Rev ($593M) (0 disclosures) for PACS.
DVA screens cheaper on headline valuation multiples. DVA trades at 9.5x Forward P/E, 11.8x Trailing P/E, 0.40x PEG, and 1.6x EV/Revenue (9.1% FCF margin), whereas PACS trades at 15.3x Forward P/E, 26.2x Trailing P/E, 1.22x PEG, and 1.8x EV/Revenue (0.1% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against DVA (96.8% ROE) versus PACS (26.5% ROE) capital efficiency.
In options market volatility and institutional positioning, DVA carries 42.0% implied volatility (7th %ile, Compressed (<25th %ile)), a 0.68x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (0.15β · 48% Vol realized risk). By comparison, PACS carries 46.1% implied volatility (11th %ile, Compressed (<25th %ile)), a 0.52x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.78β · 51% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.